The Europe contraceptive market is estimated to grow from $XX million in 2018 to $xx million by 2027, at a CAGR of 6.61% between 2019 and 2027. Germany dominated the overall market in terms of revenue in 2018, and Italy is expected to be the fastest growing market over the forecast period.

EUROPE CONTRACEPTIVE MARKET FORECAST 2019-2027

Europe Contraceptive Market by Education (Less Than High School, High School Graduate, College Graduate, Other College Degree) by Age Group (15–24 Years, 25–34 Years, 35–44 Years, Above 44 Years) by End-user (Households, Clinics, Hospitals) by Drugs and Devices (Contraceptives Drugs, Contraceptive Devices) by Geography.

Request free sample

Report Summary

The Europe contraceptive market is estimated to grow from $XX million in 2018 to $xx million by 2027, at a CAGR of 6.61% between 2019 to 2027. Germany dominated the overall market in terms of revenue in 2018, and Italy is expected to be the fastest growing market over the forecast period.

The United Nations Fund for Population Assistance’s, International Planned Parenthood Federation (IPPF) states that the region has the highest abortion rate in comparison to contraceptive methods. Due to the alarmingly high number of these abortions, the EU commission has launched various programs to raise awareness levels of modern contraceptive methods, which is expected to assist the growth of the market during the forecast period. Insurance agencies in Eastern Europe cover only the supplies of contraceptives and not the entire cost, thereby affecting the growth of the market. An increase in the availability of modern contraceptive is anticipated to witness a rise in contraception over the forecast period.

Germany, Italy, Spain, France, the United Kingdom and the remaining countries collectively forming the Rest of Europe regional segment are the major revenue contributors to the Europe market. In Italy, contraception, emergency contraception, and interruption of pregnancy are regulated by the laws that allow the possibility of contraceptive prescription to minors and further regulates the institution of family health centers as places aiming to promote women’s and children’s health. These laws and incentive enhance the market growth proficiently in the region.

Church & Dwight Co., Inc., Merck & Co., Inc., Mayer Laboratories, Inc., Pfizer, Inc., Pregna, Agile Therapeutics, Apothecus Pharmaceutical Corporation, Teva Pharmaceutical Industries Ltd., OCON Medical Ltd., Afaxys, Inc., Allergan Inc., Bayer AG, Okamoto Industries, Inc., Cooper Surgical Inc., and Reckitt Benckiser PLC are the major companies that have been extensively profiled in the report.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    Table of Contents

    1. RESEARCH SCOPE
      • STUDY GOALS
      • SCOPE OF THE MARKET STUDY
      • WHO WILL FIND THIS REPORT USEFUL?
      • STUDY AND FORECASTING YEARS
    2. RESEARCH METHODOLOGY
      • SOURCES OF DATA
        • SECONDARY DATA
        • PRIMARY DATA
      • TOP-DOWN APPROACH
      • BOTTOM-UP APPROACH
      • DATA TRIANGULATION
    3. EXECUTIVE SUMMARY
      • MARKET SUMMARY
      • KEY FINDINGS
        • COLLEGE GRADUATE HOLDS THE LARGEST MARKET SHARE IN TERMS OF EDUCATION
        • AGE GROUP OF 15–24 YEARS IS ANTICIPATED TO GROW SIGNIFICANTLY
        • HOUSEHOLDS ARE THE MAJOR END-USER
        • CONTRACEPTIVES DEVICES ARE WIDELY USED
    1. MARKET DYNAMICS
      • MARKET SCOPE & DEFINITION
      • MARKET DRIVERS
        • RISING CUSTOMER AWARENESS AND GOVERNMENT INITIATIVES
        • GROWING INCIDENCE OF UNWANTED PREGNANCIES
        • OCCURRENCE OF SEXUALLY TRANSMITTED DISEASES (STD)
      • MARKET RESTRAINTS
        • INCREASING AGING POPULATION
        • SIDE EFFECTS ASSOCIATED WITH THE USE OF CONTRACEPTIVE DRUGS AND DEVICES
      • MARKET OPPORTUNITIES
        • INCREASE IN AWARENESS AND IMPORTANCE REGARDING FAMILY PLANNING
        • STRATEGIC ALLIANCES AND INVESTING IN R&D
      • MARKET CHALLENGES
        • LACK OF PERCEPTION OF SOCIETY
        • INCREASING COST AND INACCESSIBILITY OF CERTAIN HEALTH SERVICES
    1. MARKET BY EDUCATION
      • LESS THAN HIGH SCHOOL
      • HIGH SCHOOL GRADUATE
      • COLLEGE GRADUATE
      • OTHER COLLEGE DEGREES
    2. MARKET BY AGE GROUP
      • 15–24 YEARS
      • 25–34 YEARS
      • 35–44 YEARS
      • ABOVE 44 YEARS
    3. MARKET BY END-USER
      • HOUSEHOLDS
      • CLINICS
      • HOSPITALS
    4. MARKET BY DRUGS AND DEVICES
      • CONTRACEPTIVES DRUGS
        • ORAL CONTRACEPTIVE PILLS
        • INJECTABLE CONTRACEPTIVES
        • TOPICAL CONTRACEPTIVES
      • CONTRACEPTIVE DEVICES
        • MALE CONDOMS
        • FEMALE CONDOMS
        • DIAPHRAGMS
        • CONTRACEPTIVE SPONGES
        • VAGINAL RINGS
        • SUBDERMAL IMPLANTS
        • INTRA-UTERINE DEVICES
          • COPPER INTRA-UTERINE DEVICES
          • HORMONAL INTRA-UTERINE DEVICES
    1. KEY ANALYTICS
      • PORTER’S FIVE FORCES MODEL
        • THREAT OF NEW ENTRANTS
        • THREAT OF SUBSTITUTE
        • BARGAINING POWER OF BUYERS
        • BARGAINING POWER OF SUPPLIERS
        • THREAT OF COMPETITIVE RIVALRY
      • PESTEL ANALYSIS
      • MARKET TRENDS
      • OPPORTUNITY MATRIX
    2. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • GERMANY
        • FRANCE
        • THE UNITED KINGDOM
        • SPAIN
        • ITALY
        • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • MARKET POSITION ANALYSIS
      • COMPANY PROFILES
        • AFAXYS, INC.
        • AGILE THERAPEUTICS
        • ALLERGAN INC.
        • APOTHECUS PHARMACEUTICAL CORPORATION
        • BAYER AG
        • CHURCH & DWIGHT CO., INC.
        • COOPER SURGICAL INC.
        • MAYER LABORATORIES, INC.
        • MERCK & CO., INC.
        • OCON MEDICAL LTD.
        • OKAMOTO INDUSTRIES, INC.
        • PFIZER, INC.
        • PREGNA
        • RECKITT BENCKISER PLC
        • TEVA PHARMACEUTICAL INDUSTRIES LTD.

    TABLE LIST

    TABLE 1        EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    TABLE 2        ASSOCIATED SIDE EFFECTS FOR DIFFERENT CONTRACEPTIVE METHOD

    TABLE 3        EUROPE CONTRACEPTIVE MARKET BY EDUCATION 2019-2027 ($ MILLION)

    TABLE 4        EUROPE LESS THAN HIGH SCHOOL MARKET 2019-2027 ($ MILLION)

    TABLE 5        EUROPE HIGH SCHOOL GRADUATE MARKET 2019-2027 ($ MILLION)

    TABLE 6        EUROPE COLLEGE GRADUATE MARKET 2019-2027 ($ MILLION)

    TABLE 7        EUROPE OTHER COLLEGE DEGREES MARKET 2019-2027 ($ MILLION)

    TABLE 8        EUROPE CONTRACEPTIVE MARKET BY AGE GROUP 2019-2027 ($ MILLION)

    TABLE 9        EUROPE 15–24 YEARS MARKET 2019-2027 ($ MILLION)

    TABLE 10      EUROPE 25–34 YEARS MARKET 2019-2027 ($ MILLION)

    TABLE 11      EUROPE 35–44 YEARS MARKET 2019-2027 ($ MILLION)

    TABLE 12      EUROPE ABOVE 44 YEARS MARKET 2019-2027 ($ MILLION)

    TABLE 13      EUROPE CONTRACEPTIVE MARKET BY END-USER 2019-2027 ($ MILLION)

    TABLE 14      EUROPE HOUSEHOLDS MARKET 2019-2027 ($ MILLION)

    TABLE 15      EUROPE CLINICS MARKET 2019-2027 ($ MILLION)

    TABLE 16      EUROPE HOSPITALS MARKET 2019-2027 ($ MILLION)

    TABLE 17      EUROPE CONTRACEPTIVE MARKET BY DRUGS AND DEVICES 2019-2027 ($ MILLION)

    TABLE 18      EUROPE CONTRACEPTIVES DRUGS MARKET 2019-2027 ($ MILLION)

    TABLE 19      EUROPE CONTRACEPTIVES DRUGS MARKET BY TYPE 2019-2027 ($ MILLION)

    TABLE 20      EUROPE ORAL CONTRACEPTIVE PILLS MARKET 2019-2027 ($ MILLION)

    TABLE 21      EUROPE INJECTABLE CONTRACEPTIVESMARKET 2019-2027 ($ MILLION)

    TABLE 22      EUROPE TOPICAL CONTRACEPTIVESMARKET 2019-2027 ($ MILLION)

    TABLE 23      EUROPE CONTRACEPTIVE DEVICES MARKET 2019-2027 ($ MILLION)

    TABLE 24      EUROPE CONTRACEPTIVE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

    TABLE 25      EUROPE MALE CONDOMS MARKET 2019-2027 ($ MILLION)

    TABLE 26      EUROPE FEMALE CONDOMS MARKET 2019-2027 ($ MILLION)

    TABLE 27      EUROPE DIAPHRAGMS MARKET 2019-2027 ($ MILLION)

    TABLE 28      EUROPE CONTRACEPTIVE SPONGES MARKET 2019-2027 ($ MILLION)

    TABLE 29      EUROPE VAGINAL RINGS MARKET 2019-2027 ($ MILLION)

    TABLE 30      EUROPE SUBDERMAL IMPLANTS MARKET 2019-2027 ($ MILLION)

    TABLE 31      EUROPE INTRA-UTERINE DEVICES MARKET 2019-2027 ($ MILLION)

    TABLE 32      EUROPE INTRA-UTERINE DEVICES MARKET BY TYPE 2019-2027 ($ MILLION)

    TABLE 33      EUROPE COPPER INTRA-UTERINE DEVICES MARKET 2019-2027 ($ MILLION)

    TABLE 34      EUROPE HORMONAL INTRA-UTERINE DEVICES MARKET 2019-2027 ($ MILLION)

    TABLE 35      EUROPE CONTRACEPTIVE MARKET BY COUNTRY 2019-2027 ($ MILLION)

    TABLE 36      GERMANY CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

    TABLE 37      FRANCE CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

    TABLE 38      THE UNITED KINGDOM CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

    TABLE 39      SPAIN CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

    TABLE 40      ITALY CONTRACEPTIVE MARKET BY DRUGS & DEVICES 2019-2027 ($ MILLION)

    TABLE 41      CONTRACEPTIVE COMPANY MARKET POSITION ANALYSIS 2017

     

    FIGURE LIST 

    FIGURE 1      EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 2      EUROPE CONTRACEPTIVE MARKET SHARE BY EDUCATION 2018 & 2027 (%)

    FIGURE 3      EUROPE CONTRACEPTIVE MARKET BY LESS THAN HIGH SCHOOL 2019-2027 ($ MILLION)

    FIGURE 4      EUROPE CONTRACEPTIVE MARKET BY HIGH SCHOOL GRADUATE 2019-2027 ($ MILLION)

    FIGURE 5      EUROPE CONTRACEPTIVE MARKET BY COLLEGE GRADUATE 2019-2027 ($ MILLION)

    FIGURE 6      EUROPE CONTRACEPTIVE MARKET BY OTHER COLLEGE DEGREES 2019-2027 ($ MILLION)

    FIGURE 7      EUROPE CONTRACEPTIVE MARKET SHARE BY AGE GROUP 2018 & 2027 (%)

    FIGURE 8      EUROPE CONTRACEPTIVE MARKET BY 15–24 YEARS 2019-2027 ($ MILLION)

    FIGURE 9      EUROPE CONTRACEPTIVE MARKET BY 25–34 YEARS 2019-2027 ($ MILLION)

    FIGURE 10   EUROPE CONTRACEPTIVE MARKET BY 35–44 YEARS 2019-2027 ($ MILLION)

    FIGURE 11   EUROPE CONTRACEPTIVE MARKET BY ABOVE 44 YEARS 2019-2027 ($ MILLION)

    FIGURE 12   EUROPE CONTRACEPTIVE MARKET SHARE BY END-USER 2018 & 2027 (%)

    FIGURE 13   EUROPE CONTRACEPTIVE MARKET BY HOUSEHOLDS 2019-2027 ($ MILLION)

    FIGURE 14   EUROPE CONTRACEPTIVE MARKET BY CLINICS 2019-2027 ($ MILLION)

    FIGURE 15   EUROPE CONTRACEPTIVE MARKET BY HOSPITALS 2019-2027 ($ MILLION)

    FIGURE 16   EUROPE CONTRACEPTIVE MARKET SHARE BY DRUGS AND DEVICES 2018 & 2027 (%)

    FIGURE 17   EUROPE CONTRACEPTIVE MARKET BY CONTRACEPTIVES DRUGS 2019-2027 ($ MILLION)

    FIGURE 18   EUROPE CONTRACEPTIVES DRUGS MARKET BY ORAL CONTRACEPTIVE PILLS 2019-2027 ($ MILLION)

    FIGURE 19   EUROPE CONTRACEPTIVES DRUGS MARKET BY INJECTABLE CONTRACEPTIVES 2019-2027 ($ MILLION)

    FIGURE 20   EUROPE CONTRACEPTIVES DRUGS MARKET BY TOPICAL CONTRACEPTIVES 2019-2027 ($ MILLION)

    FIGURE 21   EUROPE CONTRACEPTIVE MARKET BY CONTRACEPTIVE DEVICES 2019-2027 ($ MILLION)

    FIGURE 22   EUROPE CONTRACEPTIVE DEVICES MARKET BY MALE CONDOMS 2019-2027 ($ MILLION)

    FIGURE 23   EUROPE CONTRACEPTIVE DEVICES MARKET BY FEMALE CONDOMS 2019-2027 ($ MILLION)

    FIGURE 24   EUROPE CONTRACEPTIVE DEVICES MARKET BY DIAPHRAGMS 2019-2027 ($ MILLION)

    FIGURE 25   EUROPE CONTRACEPTIVE DEVICES MARKET BY CONTRACEPTIVE SPONGES 2019-2027 ($ MILLION)

    FIGURE 26   EUROPE CONTRACEPTIVE DEVICES MARKET BY VAGINAL RINGS 2019-2027 ($ MILLION)

    FIGURE 27   EUROPE CONTRACEPTIVE DEVICES MARKET BY SUBDERMAL IMPLANTS 2019-2027 ($ MILLION)

    FIGURE 28   EUROPE CONTRACEPTIVE DEVICES MARKET BY INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

    FIGURE 29   EUROPE INTRA-UTERINE DEVICES MARKET BY COPPER INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

    FIGURE 30   EUROPE INTRA-UTERINE DEVICES MARKET BY HORMONAL INTRA-UTERINE DEVICES 2019-2027 ($ MILLION)

    FIGURE 31   PORTER’S FIVE FORCE MODEL

    FIGURE 32   GERMANY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 33   FRANCE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 34   THE UNITED KINGDOM CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 35   SPAIN CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 36   ITALY CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    FIGURE 37   REST OF EUROPE CONTRACEPTIVE MARKET 2019-2027 ($ MILLION)

    Segmentation

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • GERMANY
        • FRANCE
        • THE UNITED KINGDOM
        • SPAIN
        • ITALY
        • REST OF EUROPE
    1. MARKET BY EDUCATION
      • LESS THAN HIGH SCHOOL
      • HIGH SCHOOL GRADUATE
      • COLLEGE GRADUATE
      • OTHER COLLEGE DEGREES
    2. MARKET BY AGE GROUP
      • 15–24 YEARS
      • 25–34 YEARS
      • 35–44 YEARS
      • ABOVE 44 YEARS
    3. MARKET BY END-USER
      • HOUSEHOLDS
      • CLINICS
      • HOSPITALS
    4. MARKET BY DRUGS AND DEVICES
      • CONTRACEPTIVES DRUGS
        • ORAL CONTRACEPTIVE PILLS
        • INJECTABLE CONTRACEPTIVES
        • TOPICAL CONTRACEPTIVES
      • CONTRACEPTIVE DEVICES
        • MALE CONDOMS
        • FEMALE CONDOMS
        • DIAPHRAGMS
        • CONTRACEPTIVE SPONGES
        • VAGINAL RINGS
        • SUBDERMAL IMPLANTS
        • INTRA-UTERINE DEVICES
          • COPPER INTRA-UTERINE DEVICES
          • HORMONAL INTRA-UTERINE DEVICES

    Request Free Sample

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type

      Get In Touch

      Inquire Before Buying

      Customization

      Inkwood Research delivers customized reports as per the client's requirement to provide them with an edge in the competitive market

      Request Customization

      RELATED REPORTS